News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Researchers from The University of Texas MD Anderson Cancer Center have identified a standardised protocol…
Among women with hormone receptor (HR)-positive, HER2-negative breast cancer with a high clinical risk (determined…
If you want to predict which breast cancer patients will most likely stop taking aromatase…
A large meta-analysis of breast cancer patients showed that residual cancer burden after neoadjuvant chemotherapy…
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending…
The investigational HER2-targeted antibody-drug conjugate [Fam-] trastuzumab deruxtecan (T-DXd) demonstrated durable objective responses in patients…
The presence of circulating tumour DNA (ctDNA) in early-stage triple-negative breast cancer helped predict the…
A 10-year follow-up study of breast cancer patients who had been treated with accelerated partial…
Researchers from The University of Texas MD Anderson Cancer Center today reported study results showing…
Breast cancer incidence among post menopausal women at high risk for developing the disease continued…